Company performance
Add to research
Current Price
as of May 23, 2025$0.98
P/E Ratio
N/A
Market Cap
$33.47M
Description
Add to research
Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. Its products include Triferic, CitraPure, RenalPure and SteriLyte. The company was founded by Robert L. Chioini on October 25, 1996 and is headquartered in Wixom, MI.
Metrics
Add to research
Overview
- HQWixom, MI
- SectorHealth Technology
- IndustryMedical Specialties
- TickerRMTI
- Price$0.9793-1.75%
Trading Information
- Market cap$33.47M
- Float84.00%
- Average Daily Volume (1m)239,708
- Average Daily Volume (3m)254,864
- EPS-$0.01
Company
- Revenue$97.73M
- Rev growth (1yr)-16.59%
- Net income-$1.52M
- Gross margin16.08%
- EBITDA margin-4.34%
- EBITDA-$0.82M
- EV$34.08M
- EV/Revenue0.35
- P/EN/A
- P/S0.34
- P/B1.06
- Debt/Equity40.82
Documents
Add to research
SEC Filings
Earnings Calls
Factset Street Account